Various types of antibiotics are used for treating bacteria and other types of infections. However, there are some that are resistant to penicillin and Beta-lactam antibiotics. These antibiotics must have a cell wall in order to be effective.
Beta-lactam antibiotics require a cell wall to function
During an infection, a beta-lactam antibiotic is able to kill bacteria by inactivating key enzymes involved in peptidoglycan synthesis. In a bacterial cell, the peptidoglycan layer is a vital metabolic pathway for survival. In gram-positive organisms, penicillin-binding proteins (PBP) are involved in this process. These proteins form covalent bonds between the peptidoglycan chains. Beta-lactam antibiotics inhibit PBP activity by blocking the enzymes’ transpeptidase activity. This decreases the strength of the bacterial cell wall and increases the risk of lysis. Despite the fact that b-lactam antibiotics can be used as first-line drugs against community-acquired pneumonia, the role of these drugs in the treatment of tuberculosis remains unclear. Currently, there are no beta-lactam antibiotics that have been specifically developed for the treatment of tuberculosis. In addition, resistance to b-lactam antibiotics is increasing in many bacterial species.
B-lactam antibiotics inhibit transpeptidase activity by binding to the active site of the transpeptidase enzymes. This occurs in gram-negative organisms as well as gram-positive ones. Beta-lactam antibiotics contain a four-member “beta-lactam” ring, which mimics the structure of the terminal D-Ala-D-Ala peptide of the peptidoglycan precursor. This ring is tightly bound to the transpeptidase enzyme’s active site. In the absence of beta-lactams, the D-Ala-D-Ala precursor serves as the natural substrate for transpeptidase activity. Activation of transpeptidases catalyzes the cross-linking of glycan chains, and b-lactams interfere with this process.
In addition, b-lactam antibiotics inhibit cell wall synthesis. This is facilitated by a two-component system, VxrAB, that controls the cell wall synthesis network. Specifically, vxrAB senses antibiotic exposure and stimulates a high-level b-lactam tolerance response. The response can be triggered by mutations that increase vxrAB tolerance. Alternatively, resistance can be induced by an increase in b-lactamase expression. Another mechanism for b-lactam resistance involves the expression of efflux pumps that remove antibiotics from the cell. These efflux pumps are found in gram-negative bacteria. They protect the cell against intracellular antibiotics and transport antibiotics out of the cell.
The genes encoding beta-lactamases can be located on the bacterial chromosome, on transposable elements, or on plasmids. The expression of beta-lactamases is also regulated by the extracytoplasmic function sigma factor (ECF sigma factor). This ECF sigma factor is a coiled-coil-shaped protein that is found in all Bacillus species. ECF sigma factor is involved in the control of beta-lactamase expression in Bacillus cereus group species.
B-lactam antibiotics interact with a penicillin-binding protein (PBP) that forms cross-links between peptidoglycan chains. This interaction may determine whether the antibiotic is effective in killing the bacterial cell. Beta-lactam antibiotics interfere with the function of PBPs, and the properties of peptidoglycan may not affect b-lactam susceptibility. However, PBPs are essential for the cell wall synthesis pathway, and mutations in the b-lactam-binding properties of PBPs can result in low affinity for b-lactams. This phenomenon is often referred to as target site modification. When an individual PBP acquires a mutation that changes its affinity for b-lactams, the b-lactam is no longer able to bind the PBP. However, the altered PBP still has an enzymatic activity for cell wall synthesis.
Staphylococcus aureus resistant to penicillin
Among the many bacteria that can cause infections in humans, Staphylococcus aureus has been reported to be among the most resistant. This phenomenon is due to the spread of resistance genes from one genus to another through various means, including horizontal gene transfer. As such, it is important to identify resistance mechanisms in order to conduct surveillance on antibiotic resistance in Staph aureus. Among the antibiotics used, penicillin resistance is the most common. However, the distribution of penicillin resistance differs from region to region. In Norway, for example, penicillin resistance ranges from 2% to 70%. However, in Europe, penicillin resistance is generally 32%.
Antibiotic resistance phenotypes were determined in isolates by antibiotic susceptibility testing. Isolates were classified according to their antibiotic susceptibility and growth at the appropriate breakpoint MIC. The most common antibiotics used were penicillin and erythromycin. The most resistant isolates were resistant to all of the antibiotics in the study, whereas the most susceptible isolates were resistant to only one of the antibiotics in the study. In addition, isolates were classified according to their inhibition zones. These zones were measured to millimeters. The antibiotics used were penicillin G, erythromycin, vancomycin, ceftriaxone, and sulfadimethoxine. The antibiotics used were also recorded according to their manufacturers’ recommendations.
Bacterial identification was performed using the gram staining method and oxidase. Pure cultures were evaluated for staining characteristics and biochemical reactions. PFGE typing was performed on 288 Staphylococcus aureus isolates. Twenty-nine PFGE types were obtained and assigned to six lineage groups. The PFGE typing method had better discriminatory power than phage typing. A subset of isolates was examined for sensitivity to 10 antimicrobial compounds. These compounds included: penicillin G, erythromycin, ceftriaxone, sulfadimethoxine, nalidixic acid, and vancomycin.
The most common antibiotics used by Staph aureus isolates were penicillin and erythromycin. Resistance to penicillin was reported in a small proportion of isolates but was the most common antibiotic. Isolates were classified as susceptible or intermediate resistant based on the results of the antibiotic susceptibility test. The most resistant isolates were resistant to chloramphenicol, erythromycin, and tetracycline. In addition, isolates were classified as intermediate resistant based on their growth at the appropriate breakpoint MIC.
The antibiotic discs used for antibiotic susceptibility testing were provided by the manufacturer. The discs were placed on a Mueller-Hinton agar surface and gently pressed to ensure that the antibiotic would contact the surface. The antibiotics were incubated aerobically at 37 deg C for 18 h to 24 h. The results were recorded and interpreted according to the manufacturer’s table.
In addition to penicillin resistance, Staphylococcus aureus was resistant to sulfadimethoxine and sulfadimethoxine was the second most common antimicrobial in the study. A total of 69 isolates were resistant to multiple antibiotics. This resistance was seen in 17.9% of isolates from large-scale farms and 22% of isolates from small-scale farms. Among large-scale farms, treatment records were available from 73% of the farms. However, only 22% of the isolates from small-scale farms had treatment records. This finding indicates that the documentation of treatment records for antimicrobial drugs on small-scale farms is lower.
Among the many public health problems facing the 21st century, antibiotic resistance is one of the most pressing. Over 70 percent of hospital-acquired infections involve bacteria that are resistant to at least one antibiotic. This means that the accelerated development of new antibiotics is being overtaken by the pace at which bacteria are developing resistance to these drugs. As such, the development of new strategies to combat antibiotic resistance is critical.
One way to combat antibiotic resistance is to prevent it in the first place. Various public health agencies have launched educational posters and campaigns to promote good hygiene practices and avoid unnecessary antibiotic use. Several international funding agencies have pledged to develop strategies to fight antibiotic resistance. Despite these efforts, infections remain a leading cause of death in developing countries. As a result, improving sanitation and drinking water is crucial to combating antimicrobial resistance.
Another way to combat antibiotic resistance is to isolate the etiological agent and treat it in a clinical setting. However, this is not always possible. Some bacteria naturally resist antibiotics, while others are acquired through horizontal gene transfer. For example, MRSA is one bacterial mutant that is naturally resistant to antibiotics. However, this type of resistance is often associated with an increased risk of hospitalization.
The emergence of antimicrobial resistance is inevitable, given the variety of bacteria that can grow powerful enough to resist antibiotics. Nonetheless, determining which bacteria are susceptible to which antibiotics is helpful, as is knowing the best way to combat resistance. However, managing resistance in a drug-dominated environment is a complex and difficult task. It is important to note that the process of determining which bacteria are susceptible to which antibiotics require a basic knowledge of bacterial cell anatomy and biology.
One way to determine which bacteria are susceptible to which antibiotics are to perform a disc diffusion test. This test involves a bacterial culture inoculated on agar plates and a disc containing an appropriate antibiotic. Various drugs were tested in rotation at each rotation. For example, a culture was inoculated with 50 mg/ml of streptomycin. Next, the disc was streaked with the appropriate antibiotic. After this process, the growth rate was measured and the probability of mutations to restore the bacteria to a harmless state was computed.
This study examined the effects of six antibiotics on the growth rates of two bacterial populations. The study was carried out in two university hospitals in Lebanon. The results of this study will be of use to physicians in the future, as they hope to determine the most effective treatment strategies for bacteria.
Similarly, a study by researchers at UC Merced in California looked at the evolution of resistance in some of the most commonly used antibiotics. They found that many of the antibiotics listed on the bottle are able to reversibly inhibit a resistance phenotype.
Health A to Z. (n.d.). HSE.ie. https://www2.hse.ie/az/
U.S. National Library of Medicine. (n.d.). https://www.ncbi.nlm.nih.gov/
Directory Health Topics. (n.d.). https://www.healthline.com/directory/topics
Health A-Z. (2022, April 26). Verywell Health. https://www.verywellhealth.com/health-a-z-4014770
Harvard Health. (2015, November 17). Health A to Z. https://www.health.harvard.edu/health-a-to-z
Health Conditions A-Z Sitemap. (n.d.). EverydayHealth.com. https://www.everydayhealth.com/conditions/